Symbols / AIMD $1.49 +3.47% Ainos, Inc.

Technology • Scientific & Technical Instruments • United States • NCM
AIMD Chart
About

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Fundamentals
Scroll to Statements
Sector Technology Industry Scientific & Technical I Market Cap 10.83M
Enterprise Value 21.05M Income -14.77M Sales 124.16K
Book/sh 1.29 Cash/sh 0.06 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E — PEG —
P/S 87.20 P/B 1.16 P/C —
EV/EBITDA -2.29 EV/Sales 169.51 Quick Ratio 0.39
Current Ratio 1.06 Debt/Eq 145.45 LT Debt/Eq —
EPS (ttm) -3.46 EPS next Y — EPS Growth —
Revenue Growth — Earnings 2007-03-26 15:00 ROA -35.19%
ROE -128.00% ROIC — Gross Margin 82.89%
Oper. Margin -386.48% Profit Margin 0.00% Shs Outstand 7.27M
Shs Float 3.24M Short Float 1.73% Short Ratio 0.43
Short Interest — 52W High 4.50 52W Low 1.26
Beta — Avg Volume 659.66K Volume 25.10K
Target Price — Recom None Prev Close $1.44
Price $1.49 Change 3.47%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.49
Latest analyst target
3. DCF / Fair value
$-11.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.49
Low
—
High
—
Mean
—
News
RSS: Latest AIMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-28 TAIWAN CARBON NANO TECHNOLOGY CORP Beneficial Owner of more than 10% of a Class of Security — 46,000 $2.17 $99,806
2026-01-09 TAIWAN CARBON NANO TECHNOLOGY CORP Beneficial Owner of more than 10% of a Class of Security — 1,281 $1.80 $2,336
2025-11-25 LEE HSIN LIANG CHRISTOPHER Chief Financial Officer — 20,000 $2.10 $42,000
2025-11-25 TSAI CHUN-HSIEN Chief Executive Officer — 80,000 $2.10 $168,000
2025-11-25 CHIANG YAO-CHUNG Director — 50,000 $2.10 $105,000
2025-11-25 TSAI CHUNG-YI Director — 50,000 $2.10 $105,000
2025-11-25 TSAI CHUN-JUNG Director — 80,000 $2.10 $168,000
2025-11-25 CHANG WEN-HAN Director — 50,000 $2.10 $105,000
2025-11-25 LEE TING CHUAN Director — 80,000 $2.10 $168,000
2025-11-25 WEI PAO- SHENG Director — 50,000 $2.10 $105,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.12
+498.95%
0.02
-83.02%
0.12
-96.53%
3.52
Operating Revenue
0.12
+498.95%
0.02
-83.02%
0.12
-96.53%
3.52
Cost Of Revenue
0.02
-59.60%
0.05
-86.01%
0.38
-82.22%
2.11
Reconciled Cost Of Revenue
0.02
-59.60%
0.05
-86.01%
0.38
-82.22%
2.11
Gross Profit
0.10
+422.95%
-0.03
+87.44%
-0.25
-118.05%
1.41
Operating Expense
14.09
+2.06%
13.81
+6.61%
12.95
-15.79%
15.38
Research And Development
7.75
-7.89%
8.41
+14.99%
7.32
+6.89%
6.85
Selling General And Administration
6.34
+17.57%
5.40
-4.26%
5.64
-33.98%
8.54
Total Expenses
14.11
+1.82%
13.86
+4.00%
13.33
-23.82%
17.50
Operating Income
-13.99
-1.08%
-13.84
-4.81%
-13.21
+5.51%
-13.98
Total Operating Income As Reported
-13.99
-1.08%
-13.84
-4.81%
-13.21
+5.51%
-13.98
EBITDA
-9.28
+1.76%
-9.44
-7.88%
-8.75
+4.00%
-9.12
Normalized EBITDA
-9.28
+1.76%
-9.44
-7.88%
-8.75
+4.00%
-9.12
Reconciled Depreciation
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
EBIT
-14.06
+1.32%
-14.25
-4.55%
-13.63
+2.35%
-13.95
Total Unusual Items
—
—
-0.43
—
Total Unusual Items Excluding Goodwill
—
—
-0.43
—
Net Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Pretax Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Non Operating Interest Income Expense
-0.71
-15.48%
-0.62
-327.53%
-0.14
-169.38%
-0.05
Interest Expense Non Operating
0.71
+15.48%
0.62
+327.53%
0.14
+169.38%
0.05
Net Interest Income
-0.71
-15.48%
-0.62
-327.53%
-0.14
-169.38%
-0.05
Interest Expense
0.71
+15.48%
0.62
+327.53%
0.14
+169.38%
0.05
Other Income Expense
-0.07
+83.22%
-0.40
+3.45%
-0.42
-1918.48%
0.02
Other Non Operating Income Expenses
-0.07
+83.22%
-0.40
+3.45%
-0.42
-1918.48%
0.02
Gain On Sale Of Security
—
—
-0.43
—
Tax Provision
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income From Continuing Operation Net Minority Interest
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income From Continuing And Discontinued Operation
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income Continuous Operations
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Normalized Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income Common Stockholders
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Diluted EPS
-3.46
+55.75%
-7.82
+53.45%
-16.80
+34.63%
-25.70
Basic EPS
-3.46
+55.75%
-7.82
+53.45%
-16.80
+34.63%
-25.70
Basic Average Shares
4.27
+124.69%
1.90
+131.90%
0.82
+50.25%
0.55
Diluted Average Shares
4.27
+124.69%
1.90
+131.90%
0.82
+50.25%
0.55
Diluted NI Availto Com Stockholders
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Total Other Finance Cost
—
0.31
-41.34%
0.53
—
Line Item Trend 2025-12-31
Total Assets
20.87
Current Assets
1.14
Cash Cash Equivalents And Short Term Investments
0.42
Cash And Cash Equivalents
0.42
Receivables
0.00
Accounts Receivable
0.00
Inventory
0.30
Raw Materials
0.12
Work In Process
0.11
Finished Goods
0.07
Other Current Assets
0.43
Total Non Current Assets
19.73
Net PPE
0.34
Gross PPE
1.75
Accumulated Depreciation
-1.41
Machinery Furniture Equipment
1.75
Construction In Progress
—
Goodwill And Other Intangible Assets
19.23
Other Intangible Assets
19.23
Other Non Current Assets
0.16
Total Liabilities Net Minority Interest
13.31
Current Liabilities
1.08
Payables And Accrued Expenses
0.73
Payables
—
Current Accrued Expenses
0.73
Current Debt And Capital Lease Obligation
—
Current Debt
—
Other Current Borrowings
—
Current Deferred Liabilities
0.35
Current Deferred Revenue
0.35
Total Non Current Liabilities Net Minority Interest
12.23
Long Term Debt And Capital Lease Obligation
11.00
Long Term Debt
11.00
Long Term Capital Lease Obligation
—
Other Non Current Liabilities
1.23
Stockholders Equity
7.56
Common Stock Equity
7.56
Capital Stock
0.07
Common Stock
0.07
Preferred Stock
0.00
Share Issued
7.04
Ordinary Shares Number
5.88
Treasury Shares Number
1.16
Additional Paid In Capital
77.23
Retained Earnings
-67.52
Gains Losses Not Affecting Retained Earnings
-0.25
Treasury Stock
1.97
Total Equity Gross Minority Interest
7.56
Total Capitalization
18.56
Working Capital
0.06
Invested Capital
18.56
Total Debt
11.00
Net Debt
10.58
Capital Lease Obligations
—
Net Tangible Assets
-11.66
Tangible Book Value
-11.66
Current Notes Payable
—
Dueto Related Parties Current
—
Foreign Currency Translation Adjustments
-0.25
Other Equity Interest
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.61
+20.55%
-5.81
-23.72%
-4.69
-54.39%
-3.04
Cash Flow From Continuing Operating Activities
-4.61
+20.55%
-5.81
-23.72%
-4.69
-54.39%
-3.04
Net Income From Continuing Operations
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Depreciation Amortization Depletion
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
Depreciation And Amortization
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
Other Non Cash Items
2.92
+635.04%
0.40
-83.93%
2.47
—
Stock Based Compensation
1.73
-51.23%
3.54
+217.83%
1.11
-82.64%
6.42
Asset Impairment Charge
—
0.00
-100.00%
0.52
0.00
Operating Gains Losses
-0.00
—
—
—
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
0.28
+392.57%
-0.09
0.00
Gain Loss On Sale Of PPE
-0.00
0.00
—
0.00
Change In Working Capital
0.73
+1862.98%
0.04
-80.44%
0.19
+165.59%
-0.29
Change In Receivables
0.00
-91.48%
0.00
-99.80%
0.20
+199.77%
-0.20
Changes In Account Receivables
0.00
-91.48%
0.00
-99.80%
0.20
+199.77%
-0.20
Change In Inventory
-0.15
-736.86%
0.02
-89.25%
0.22
+137.26%
-0.60
Change In Prepaid Assets
—
—
—
—
Change In Payables And Accrued Expense
1.00
+1050.69%
-0.11
-1031.76%
-0.01
-103.94%
0.24
Change In Accrued Expense
1.00
+1050.69%
-0.11
-1031.76%
-0.01
-103.94%
0.24
Change In Payable
—
—
—
—
Change In Account Payable
—
—
—
—
Change In Other Working Capital
—
—
0.11
—
Change In Other Current Assets
-0.12
-203.92%
0.12
+152.94%
-0.22
-182.74%
0.27
Investing Cash Flow
-0.00
+98.23%
-0.13
-23.41%
-0.10
+83.89%
-0.63
Cash Flow From Continuing Investing Activities
-0.00
+98.23%
-0.13
-23.41%
-0.10
+83.89%
-0.63
Net PPE Purchase And Sale
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Purchase Of PPE
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Capital Expenditure
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Net Other Investing Changes
0.03
+131.11%
-0.10
-1117.20%
-0.01
-334.32%
0.00
Financing Cash Flow
1.01
-87.43%
8.03
+63.00%
4.92
+27.86%
3.85
Cash Flow From Continuing Financing Activities
1.01
-87.43%
8.03
+63.00%
4.92
+27.86%
3.85
Net Issuance Payments Of Debt
-1.00
-112.31%
8.12
+52.87%
5.31
+156.64%
2.07
Issuance Of Debt
0.00
-100.00%
9.88
+64.58%
6.00
+172.73%
2.20
Repayment Of Debt
-1.00
+42.91%
-1.75
-155.35%
-0.69
-430.14%
-0.13
Long Term Debt Issuance
0.00
-100.00%
9.88
+64.58%
6.00
+172.73%
2.20
Long Term Debt Payments
-1.00
+42.91%
-1.75
-155.35%
-0.69
-430.14%
-0.13
Net Long Term Debt Issuance
-1.00
-112.31%
8.12
+52.87%
5.31
+156.64%
2.07
Short Term Debt Issuance
—
—
—
2.20
Short Term Debt Payments
—
—
—
-0.13
Net Short Term Debt Issuance
—
—
—
2.07
Net Common Stock Issuance
2.01
0.00
+100.00%
-0.00
-100.02%
1.78
Common Stock Payments
-0.00
0.00
+100.00%
-0.00
0.00
Repurchase Of Capital Stock
-0.00
0.00
+100.00%
-0.00
0.00
Proceeds From Stock Option Exercised
—
—
—
0.00
Net Other Financing Charges
—
-0.10
+75.00%
-0.39
-121.91%
1.78
Changes In Cash
-3.61
-272.47%
2.09
+1541.19%
0.13
-29.13%
0.18
Effect Of Exchange Rate Changes
0.13
+256.54%
-0.08
+10.84%
-0.10
-22.04%
-0.08
Beginning Cash Position
3.89
+106.45%
1.89
+1.74%
1.85
+5.82%
1.75
End Cash Position
0.42
-89.28%
3.89
+106.45%
1.89
+1.74%
1.85
Free Cash Flow
-4.65
+20.25%
-5.83
-21.76%
-4.79
-30.29%
-3.67
Interest Paid Supplemental Data
0.00
-99.85%
0.02
+28.25%
0.02
-60.94%
0.04
Income Tax Paid Supplemental Data
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Common Stock Issuance
2.01
0.00
0.00
-100.00%
1.78
Issuance Of Capital Stock
2.01
0.00
0.00
-100.00%
1.78
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category